Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ampicillin | HCID 6249 | — |
| Reactant | Maleic Acid | HCID 444266 | — |
| Catalyst | Platinum | HCID 23939 | — |
| Product | Maleic Acid | HCID 444266 | — |
| Product | Fumaric Acid | HCID 444972 | — |
Reaction Steps
The ampicillin-resistant transformant was selected by measuring its enzyme activity of isomerizing maleic acid. The ampicillin-resistant transformant was inoculated via a loop of platinum into 3 ml maleic acid medium (Table 1) containing 100 γ ampicillin and cultured overnight, and the microorganism was recovered by centrifuging 1.5 ml of the culture. The recovered microorganism was suspended in 1 ml of 20% maleic acid substrate solution (Table 2) and reacted at 30° C. overnight. This substrate solution contained aspartase prepared from E. coli so that fumaric acid formed by isomerization of maleic acid was converted into L-aspartic acid. After overnight reaction, a part of the reaction solution was diluted 400-fold with distilled water and measured for its formed L-aspartic acid by HPLC analysis. The conditions for HPLC analysis were as described in item (2) in Example 1.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06133014 |
|---|
| Source dataset | uspto-grants-2000_10 |
|---|
| ORD ID | ord-6d54da814d2d4eabac67e5fa5a5b25b8 |
|---|
| Source note | uspto-grants-2000_10 |
|---|